down arrow

Amrutanjan Healt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE098F01031
  • NSEID: AMRUTANJAN
  • BSEID: 590006
INR
635.55
1.85 (0.29%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Standalone Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2024 is 4.92% vs 19.81% in Dec 2023

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 10.32% vs 62.93% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2024 is 8.21% vs 77.38% in Dec 2023

stock-summary

Interest

YoY Growth in quarter ended Dec 2024 is 20.00% vs 150.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023

Compare Quarterly Results Of Amrutanjan Healt With
Markets Mojo
Figures in Rs cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
122.75
2,396.57
-2,273.82
-94.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
122.75
2,396.57
-2,273.82
-94.88%
Raw Material Cost
25.98
179.72
-153.74
-85.54%
Purchase of Finished goods
30.46
445.60
-415.14
-93.16%
(Increase) / Decrease In Stocks
-0.64
34.08
-34.72
-101.88%
Employee Cost
14.70
521.79
-507.09
-97.18%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
16.56
0.00
16.56
Other Expenses
12.35
474.45
-462.10
-97.40%
Total Expenditure (Excl Depreciation)
99.41
1,655.64
-1,556.23
-94.00%
Operating Profit (PBDIT) excl Other Income
23.34
740.93
-717.59
-96.85%
Other Income
4.36
69.82
-65.46
-93.76%
Operating Profit (PBDIT)
27.70
810.75
-783.05
-96.58%
Interest
0.06
199.47
-199.41
-99.97%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
27.64
611.28
-583.64
-95.48%
Depreciation
1.66
87.03
-85.37
-98.09%
Profit Before Tax
25.99
524.25
-498.26
-95.04%
Tax
6.74
107.87
-101.13
-93.75%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
19.25
416.38
-397.13
-95.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
19.25
416.38
-397.13
-95.38%
Equity Capital
2.89
40.06
-37.17
-92.79%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.66
10.39
-3.73
-35.90%
Diluted Earnings per share
6.66
10.33
-3.67
-35.53%
Operating Profit Margin (Excl OI)
19.01%
30.92%
0.00
-11.91%
Gross Profit Margin
22.52%
25.51%
0.00
-2.99%
PAT Margin
15.68%
17.37%
0.00
-1.69%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 122.75 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 11.67% vs 31.26% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 4.92% vs 19.81% in Dec 2023

Quarterly - Standalone Net Profit
Standalone Net Profit 19.25 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 63.14% vs 155.41% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 10.32% vs 62.93% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.34 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 71.62% vs 282.02% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 8.21% vs 77.38% in Dec 2023

Quarterly - Interest
Interest 0.06 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 20.00% vs 150.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.01%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023